中国药物警戒 ›› 2022, Vol. 19 ›› Issue (7): 712-716.
DOI: 10.19803/j.1672-8629.2022.07.04
• 机制性模型在药物研发和评价中的应用专栏(一) • 上一篇 下一篇
张斗胜, 王晨#, 许明哲*
收稿日期:
2022-02-15
出版日期:
2022-07-15
发布日期:
2022-07-12
通讯作者:
*许明哲,男,博士,主任药师,抗感染药物质量评价研究。E-mail:xumzhe@nifdc.org.cn。#为共同通信作者。
作者简介:
张斗胜,男,博士,主任药师,抗感染药物质量评价研究。
基金资助:
ZHANG Dousheng, WANG Chen#, XU Mingzhe*
Received:
2022-02-15
Online:
2022-07-15
Published:
2022-07-12
摘要: 目的 快速评价注射用左奥硝唑及其主要杂质的潜在神经毒性,为加强临床用药安全性提供参考。方法 利用在线数据库准备建模数据,分别采用人工神经网络和支持向量机算法构建2种不同原理的分类预测模型进行交互快速评价,并采用特征结构域初步探索毒性成因。结果 新建模型中,编号为ANN-3和SVM-2模型预测的假阳性、假阴性结果均小于4.0%,其灵敏度、准确性和稳健性良好;采用新建模型预测评估注射用左奥硝唑及3个主要杂质具有潜在神经毒性,可信度高于90%;特征结构域分析显示结构中羟基取代增加分子极性,是表现出潜在神经毒性的可能原因。结论 左奥硝唑及其主要杂质均表现出潜在神经毒性,需要密切关注注射剂在临床使用中的安全性;也为其他抗生素药物及其杂质的毒性快速识别与评价提供借鉴。
中图分类号:
张斗胜, 王晨, 许明哲. 基于计算模型结合数据库技术快速评价注射用左奥硝唑及其主要杂质的潜在神经毒性[J]. 中国药物警戒, 2022, 19(7): 712-716.
ZHANG Dousheng, WANG Chen, XU Mingzhe. Rapid evaluation of potential neurotoxicity of levornidazole for injection and its main impurities based on computational models and database technology[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 712-716.
[1] ZHANG Q, YAN JZ, YAO W, et al.Study on the legal system of drug reevaluation in america, european union, Japan and the Enlightenment to China[J]. China Pharmacy(中国药房), 2019, 30(18): 2449-2454. [2] ZHANG YP, SONG SY, BAO LL.Relationship between mechanism and chemical structure of adverse reactions of fluoroquinolones[J]. China & Foreign Medical Treatment(中外医疗), 2014, 33(7): 130-131. [3] GE YQ, YE XX, LE J, et al.Research progress on toxicity and detection methods of N-nitrosamines genotoxic impurities[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2020, 40(1): 83-89. [4] ADAMSON RH, CHABNER BA.The finding of N-nitrosod-imethylamine in common medicines[J]. The Oncologist, 2020, 25(6): 460-462. [5] MICHAEL WC.Understanding and preventing (N-nitrosod-imethylamine) NDMA contamination of medications[J]. The Annals of Pharmacotherapy, 2020, 54(6): 611-614. [6] HU JL, WU T, ZHU DM, et al.In vitro activity of a new antibac-terial agent levornidazole against anaerobic bacteria[J]. Chinese Journal of Infection and Chemotherapy(中国感染与化疗杂志), 2014, 14(2): 18-21. [7] LI WW, YAO MN, ZHAO X, et al.Systematic evaluation of levornidazole in the treatment of anaerobic infection[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2019, 28(3): 13-19. [8] HU J, ZHANG J, CHEN Y, et al.In vitro anaerobic pharma-cokinetic/ pharmacodynamic model to simulate the bactericidal activity of levornidazole against bacteroides fragilis[J]. Clinical Therapeutics, 2017, 39(4): 828-836. [9] ZHAO Y, CHEN Z, HUANG P, et al.Analysis of ornidazole injection in clinical use at post-marketing stage by centralized hospital monitoring system[J]. Current Medical Science, 2019, 39(5): 836-842. [10] SUN JH, WANG ZQ, GU XL, et al.Comparative study of ornidazole enantiomers on the toxic and side effects to central nervous system in mice[J]. Journal of China Pharmaceutical University(中国药科大学学报), 2008, 39(4): 343-347. [11] BAI YT, NAN N, YIN J.Discussion on toxicity prediction of quantitative structure-activity relationship model and its application in impurity prediction[J]. Chinese Pharmaceutical Affairs(中国药事), 2019, 33(10): 1174-1180. [12] LI L, YANG JB.Application progress of physiologically-based pharmacokinetic model in clinicaldevelopment of novel molecular entities[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2017, 33(17): 118-122. [13] PURI M, PATHAK YV, SUTATIYA VK, et al Artificial neural network for drug design, delivery and disposition[M]. Academic press: Salt lake city, USA, 2016: 181-193. [14] SAMUI P, ROY SS, VALENTINA EB.Handbook of neural computation[M]. Academic press: Salt Lake City, USA, 2017: 515-535. [15] GAO YF, FENG JF, ZHU L.Toxicodynamic modeling of zebrafish larvae to metals using stochastic death and individual tolerance models: comparisons of model assumptions, parameter sensitivity and predictive performance[J]. Ecotoxicology, 2017, 26(3): 295-307. [16] AUSTIN JD, HIRSTEIN J, WALEN S.Integrated mathematics interfaced with science[J]. School Science and Mathematics, 1997, 97(1): 45-49. [17] PABLO MC, PARDO-FERNÁNDEZ JC. The youden index in the generalized receiver operating characteristic curve context[J]. The International Journal of Biostatistics, 2019, 15(1): 1-20. [18] JOHN AC.Classical and modern regression with applications[J]. Technometrics, 2012, 29(3): 377-378. [19] KUHN M, LETUNIC I, JENSEN LJ, et al.The SIDER database of drugs and side effects[J]. Nucleic Acids Research, 2016, 44(D1): D1075-D1079. [20] LEI TL, LI YY, SONG YL, et al.ADMET evaluation in drug discovery: 15 accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling[J]. Journal of Cheminformatics, 2016, 8(1): 1-19. |
[1] | 李欣颖, 包蕾, 李舒冉, 赵荣华, 孙静, 谢丹, 鲍岩岩, 郭姗姗, 崔晓兰, 耿子涵. 疏风解毒胶囊对甲型流感病毒H1N1特异性抗体的影响[J]. 中国药物警戒, 2025, 22(8): 841-850. |
[2] | 王馨蔚, 彭一峰, 孙静, 冀祖恩, 包蕾, 罗恒磊, 耿子涵, 张虎娟, 李舒冉, 张敬升, 郭姗姗, 崔晓兰, 赵荣华. 一叶抗流感胶囊对人冠状病毒229E感染致小鼠肺炎的影响[J]. 中国药物警戒, 2025, 22(8): 851-855. |
[3] | 谢锐, 孙绮悦, 李艳英, 张敬升, 赵荣华, 郭姗姗, 耿子涵, 包蕾, 高双荣, 崔晓兰, 谢丹, 孙静. 双参苓颗粒对镉中毒致小鼠慢性肾功能衰竭模型的影响[J]. 中国药物警戒, 2025, 22(8): 856-862. |
[4] | 陈思颖, 丁雪丽, 刘淑佳, 张晓朦, 张冰, 林志健. 中草药心脏毒性预测模型研究[J]. 中国药物警戒, 2025, 22(8): 869-875. |
[5] | 蔡海丽, 张晓朦, 刘亚迪, 陈莉娟, 王雨, 张冰. 基于铁死亡探讨中药防治蒽环类药物心脏毒性的机制[J]. 中国药物警戒, 2025, 22(8): 876-882. |
[6] | 郑海云, 王志钢, 吴宏伟, 王少南, 王斌. 基于UPLC-Q-Exactive Orbitrap HRMS的补心安眠汤体内外化学成分分析[J]. 中国药物警戒, 2025, 22(8): 883-888. |
[7] | 孙雅, 王旭, 孙志, 周玉冰. 脓毒症伴急性肾损伤重症患者利奈唑胺剂量分析[J]. 中国药物警戒, 2025, 22(8): 889-895. |
[8] | 史琪, 王建新, 王桂杰, 陆悦阳, 主佳旭, 高蕊. 清气化痰丸治疗慢性阻塞性肺疾病急性加重的系统评价[J]. 中国药物警戒, 2025, 22(8): 914-919. |
[9] | 应婕, 徐霄龙, 李博, 刘腾文, 刘清泉. 金花清感颗粒治疗轻型流感临床应用的Meta分析[J]. 中国药物警戒, 2025, 22(8): 920-923. |
[10] | 柯秀琴, 海学武. 433例羟苯磺酸钙胶囊不良反应分析[J]. 中国药物警戒, 2025, 22(8): 924-927. |
[11] | 梁洁. 172例抗肿瘤药品不良反应报告分析[J]. 中国药物警戒, 2025, 22(8): 928-932. |
[12] | 刘疆, 陈洁, 邱思鸿, 李娜, 周莹, 陈永刚, 罗季. 基于美国FAERS数据库的奥马环素和莫西沙星不良事件分析[J]. 中国药物警戒, 2025, 22(8): 933-936. |
[13] | 赵牡丹, 朱明辉, 张欢, 赵远洋, 秦靖. 1例彭氏变形杆菌致糖尿病足感染的药学监护[J]. 中国药物警戒, 2025, 22(8): 937-940. |
[14] | 周玗洁, 黄晓婧, 陈明月, 杜鹏强, 王爱凤. 注射用头孢哌酮舒巴坦钠致重度血小板减少2例分析[J]. 中国药物警戒, 2025, 22(8): 941-943. |
[15] | 陈桦宝, 刘薇, 蒋婷, 郑玲利, 李静. 盐酸纳洛酮注射液致急性戒断综合征1例分析[J]. 中国药物警戒, 2025, 22(8): 944-946. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||